TScan Therapeutics, Inc.
TCRX
$1.44
$0.1410.77%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.00% | -8.92% | 82.87% | -15.24% | -10.85% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -11.91% | 59.92% | -4.33% | -11.63% | 2.29% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 6.80% | -8.49% | 81.84% | -15.20% | -10.72% |
|
|||||
Total Current Assets | 6.80% | -8.49% | 81.84% | -15.20% | -10.72% |
Net Property, Plant & Equipment | 6.70% | -2.13% | -1.25% | -2.53% | 6.11% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -0.60% | 0.90% | 1.48% | 0.00% | 0.00% |
Total Assets | 6.63% | -7.16% | 55.66% | -11.51% | -6.60% |
|
|||||
Total Accounts Payable | 17.30% | 17.27% | 46.49% | -10.57% | -25.72% |
Total Accrued Expenses | 40.25% | 3.52% | 23.81% | -17.11% | 16.56% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 17.24% | -72.06% | 37.64% | 53.72% | 20.18% |
Total Finance Division Other Current Liabilities | 15.64% | -7.02% | 2.43% | 1.22% | -32.47% |
Total Other Current Liabilities | 15.64% | -7.02% | 2.43% | 1.22% | -32.47% |
Total Current Liabilities | 25.46% | -25.70% | 22.53% | 5.56% | -10.05% |
|
|||||
Total Current Liabilities | 25.46% | -25.70% | 22.53% | 5.56% | -10.05% |
Long-Term Debt | 4.65% | 52.38% | -14.23% | -12.18% | -7.40% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 8.83% | -2.10% | -2.01% | -1.62% | 12.30% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -63.87% | -3.36% | -16.88% | -15.37% | -27.64% |
Total Liabilities | 9.42% | -0.59% | 1.51% | -2.82% | -0.93% |
|
|||||
Common Stock & APIC | 8.38% | 0.66% | 40.91% | 0.56% | 0.38% |
Retained Earnings | -10.55% | -9.66% | -11.40% | -12.17% | -8.60% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 5.19% | -10.24% | 107.55% | -18.49% | -10.71% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 5.19% | -10.24% | 107.55% | -18.49% | -10.71% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 5.19% | -10.24% | 107.55% | -18.49% | -10.71% |
|